Biovest International, Inc. Names Lymphoma Key Opinion Leader From MD Anderson Cancer Center to Scientific Advisory Board  
9/11/2012 10:13:57 AM

TAMPA, Fla. & MINNEAPOLIS--(BUSINESS WIRE)--Biovest International, Inc. (OTCQB: BVTI), a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc. (OTCQB: ABPI), today announced that it appointed Sattva S. Neelapu, M.D., Associate Professor, Department of Lymphoma/Myeloma, Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center to Biovest’s Scientific Advisory Board.